|
AU3642795A
(en)
|
1994-09-27 |
1996-04-19 |
Merck & Co., Inc. |
Endothelin receptor antagonists for the treatment of emesis
|
|
US5939431A
(en)
*
|
1996-06-20 |
1999-08-17 |
Schering Corporation |
Naphthyridines which affect IL-4 and G-CSF
|
|
AR038955A1
(es)
|
1996-12-05 |
2005-02-02 |
Amgen Inc |
Compuestos de pirimidinona y piridona sustituidos y metodos para su uso
|
|
SE0102439D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
|
WO2004078163A2
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
AU2003226927A1
(en)
|
2002-04-09 |
2003-10-27 |
7Tm Pharma A/S |
Novel carboxamide compounds for use in mch receptor related disorders
|
|
JP2006512314A
(ja)
|
2002-11-01 |
2006-04-13 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｊａｋインヒビターおよび他のプロテインキナーゼインヒビターとしての組成物の使用
|
|
US20040204422A1
(en)
|
2003-04-14 |
2004-10-14 |
Abbott Gmbh & Co. Kg. |
N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
|
|
SE0301654D0
(sv)
*
|
2003-06-05 |
2003-06-05 |
Astrazeneca Ab |
Novel compounds
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
JPWO2005040135A1
(ja)
|
2003-10-24 |
2007-03-08 |
小野薬品工業株式会社 |
抗ストレス薬およびその医薬用途
|
|
PE20060285A1
(es)
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
NZ550114A
(en)
|
2004-04-20 |
2011-02-25 |
Transtech Pharma Inc |
Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
|
|
FR2874011B1
(fr)
|
2004-08-03 |
2007-06-15 |
Sanofi Synthelabo |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
WO2006020830A2
(en)
|
2004-08-12 |
2006-02-23 |
Amgen Inc. |
Bisaryl-sulfonamides
|
|
EP1799647A1
(en)
|
2004-10-04 |
2007-06-27 |
F.Hoffmann-La Roche Ag |
Alkil-pyridines as 11-beta inhibitors for diabetes
|
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
|
SE0402735D0
(sv)
|
2004-11-09 |
2004-11-09 |
Astrazeneca Ab |
Novel compounds
|
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
|
JP5261176B2
(ja)
|
2005-08-16 |
2013-08-14 |
アイカジェン， インコーポレイテッド |
電位作動型ナトリウムチャンネル阻害剤
|
|
CN101243051A
(zh)
|
2005-08-25 |
2008-08-13 |
霍夫曼-拉罗奇有限公司 |
p38 MAP激酶抑制剂及使用它的方法
|
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
EP2016075A1
(en)
|
2006-05-03 |
2009-01-21 |
AstraZeneca AB |
Thiazole derivatives and their use as anti-tumour agents
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
US7683176B2
(en)
|
2006-07-14 |
2010-03-23 |
Chemocentryx, Inc. |
Triazolyl pyridyl benzenesulfonamides
|
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
|
EP2420494B1
(en)
|
2006-08-16 |
2014-10-08 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Use of thiadiazole compounds as inhibitors of kynurenine-3-monooxygenase
|
|
PE20080769A1
(es)
|
2006-09-08 |
2008-08-14 |
Novartis Ag |
Derivados de biaril-sulfonamida
|
|
WO2008033455A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
|
|
EP3088397B1
(en)
|
2007-04-11 |
2019-04-10 |
Canbas Co. Ltd. |
Compounds that abrogate the cell cycle g2 checkpoint for use in the treatment of cancer
|
|
US20090209536A1
(en)
|
2007-06-17 |
2009-08-20 |
Kalypsys, Inc. |
Aminoquinazoline cannabinoid receptor modulators for treatment of disease
|
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
|
US20100311736A1
(en)
|
2007-10-22 |
2010-12-09 |
Glaxosmithkline Llc |
Pyridosulfonamide derivatives as p13 kinase inhibitors
|
|
WO2009098576A1
(en)
|
2008-02-05 |
2009-08-13 |
Pfizer Inc. |
Pyridinyl amides for the treatment of cns and metabolic disorders
|
|
EP2297097A2
(en)
|
2008-06-11 |
2011-03-23 |
Irm Llc |
Compounds and compositions useful for the treatment of malaria
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
WO2010100475A1
(en)
|
2009-03-02 |
2010-09-10 |
Astrazeneca Ab |
Hydroxamic acid derivatives as gram-negative antibacterial agents
|
|
EP2421368A4
(en)
|
2009-04-20 |
2013-01-09 |
Inst Oneworld Health |
COMPOUNDS, COMPOSITIONS AND METHODS FOR PYRIDAZINE SULFONAMIDE DERIVATIVES
|
|
EP2253617A1
(de)
|
2009-05-20 |
2010-11-24 |
Bayer CropScience AG |
Halogen-substituierte Verbindungen als Pestizide
|
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
|
AR083431A1
(es)
|
2010-06-28 |
2013-02-27 |
Bayer Cropscience Ag |
Compuestos heterociclicos como pesticidas
|
|
WO2012004293A2
(de)
|
2010-07-08 |
2012-01-12 |
Bayer Cropscience Ag |
Insektizide und fungizide wirkstoffkombinationen
|
|
CN103429571A
(zh)
|
2010-12-22 |
2013-12-04 |
普渡制药公司 |
作为钠通道阻断剂的取代吡啶
|
|
US9295676B2
(en)
|
2011-03-17 |
2016-03-29 |
The Trustees Of The University Of Pennsylvania |
Mutation mimicking compounds that bind to the kinase domain of EGFR
|
|
US9056867B2
(en)
|
2011-09-16 |
2015-06-16 |
Novartis Ag |
N-substituted heterocyclyl carboxamides
|
|
WO2013134562A1
(en)
*
|
2012-03-09 |
2013-09-12 |
Inception 2, Inc. |
Triazolone compounds and uses thereof
|
|
US9896443B2
(en)
|
2012-08-21 |
2018-02-20 |
Peter Maccallum Cancer Institute |
Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereof
|
|
US20140073634A1
(en)
|
2012-08-24 |
2014-03-13 |
Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center |
Heterocyclic modulators of hif activity for treatment of disease
|
|
EP2968285A4
(en)
|
2013-03-13 |
2016-12-21 |
Flatley Discovery Lab |
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
JP2017503772A
(ja)
|
2013-12-23 |
2017-02-02 |
ノージン ビーブイ |
Ｃｃｒ９阻害剤としてのベンゼンスルホンアミド
|
|
US9745292B2
(en)
|
2014-03-13 |
2017-08-29 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions, and methods for increasing CFTR activity
|
|
MA41051B1
(fr)
|
2014-10-06 |
2020-11-30 |
Vertex Pharma |
Modulateurs du régulateur de conductance transmembranaire de la mucoviscidose
|
|
CN104844566B
(zh)
|
2014-12-12 |
2018-05-18 |
合肥中科普瑞昇生物医药科技有限公司 |
一种新型结构的激酶抑制剂
|
|
US10047051B2
(en)
*
|
2015-06-02 |
2018-08-14 |
Abbvie S.Á.R.L. |
Substituted pyridines and method of use
|
|
US9981945B2
(en)
|
2015-10-07 |
2018-05-29 |
NuBridge BioSciences |
Pyrimidine derivatives as CFTR modulators
|
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
CA3019380A1
(en)
|
2016-03-31 |
2017-10-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
TW201811766A
(zh)
|
2016-08-29 |
2018-04-01 |
瑞士商諾華公司 |
N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途
|